Long Term Complete Remission in Primary Plasma Cell Leukemia
| Autor: | Reiko Tsuyuoka, Yutaka Sasaki, Kouichi Shioi, Kumiko Tsubakimori, Yoshitaka Kurisu, Kishiko Nakamura, Takayuki Takahashi, Manabu Fukumoto, Kazuwa Nakao |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Melphalan
medicine.medical_specialty Prednisolone medicine.medical_treatment Gastroenterology Leukemia Plasma Cell Immunophenotyping Internal medicine Antineoplastic Combined Chemotherapy Protocols Internal Medicine medicine Humans Multiple myeloma Aged Plasma cell leukemia Chemotherapy business.industry Remission Induction General Medicine medicine.disease Leukemia Endocrinology medicine.anatomical_structure Female Bone marrow business medicine.drug |
| Zdroj: | Internal Medicine. 34:251-254 |
| ISSN: | 1349-7235 0918-2918 |
| DOI: | 10.2169/internalmedicine.34.251 |
| Popis: | A 76-year-old female was diagnosed as having primary plasma cell leukemia (PCL), based on abundant atypical plasma cells in the circulation and bone marrow, monoclonal kappa light chain in the serum and urine, the immunophenotype of the plasma cells and the lack of preceding multiple myeloma. The patient was treated with melphalan and prednisolone (MP), and complete remission (CR) was achieved; this was maintained for 28 months. The duration of CR in this patient appears to be the longest of those reported in well-documented primary PCL patients who have been treated with MP chemotherapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|